Article
Santa Clara, CA-VISX Inc. will pay Medjet Inc. to pursue new ophthalmictechnologies and products in exchange for a 1-year option to acquire alloutstanding Medjet common stock in a merger transaction that would pay $2cash per share.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
2 Commerce Drive
Cranbury, NJ 08512